IOVA
Iovance Biotherapeutics, Inc.
$3.93
-0.11 (-2.72%)
At close · Jul 14
Market Cap
$1.95B
Shares
446,502,396
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
79/100
Short interest 22.5% of shares — P99
Days to cover 7.1 — P90
Price vs VWAP +0.9% — P60
Short-volume trend +5.1% — P70
Short interest change -2.9% — P37
Worst FTD 0.21% of shares — P83
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 100,526,623 | 103,489,642 | -2,963,019 | 7.10 |
| 2026-06-15 | 103,489,642 | 104,249,751 | -760,109 | 7.90 |
| 2026-05-29 | 104,249,751 | 106,608,353 | -2,358,602 | 8.19 |
| 2026-05-15 | 106,608,353 | 114,711,667 | -8,103,314 | 6.00 |
| 2026-04-30 | 114,711,667 | 108,804,045 | +5,907,622 | 9.15 |
| 2026-04-15 | 108,804,045 | 110,832,243 | -2,028,198 | 6.54 |
| 2026-03-31 | 110,832,243 | 115,070,206 | -4,237,963 | 9.47 |
| 2026-03-13 | 115,070,206 | 130,927,595 | -15,857,389 | 4.98 |
| 2026-02-27 | 130,927,595 | 131,334,639 | -407,044 | 7.26 |
| 2026-02-13 | 131,334,639 | 105,255,004 | +26,079,635 | 14.61 |
| 2026-01-30 | 105,255,004 | 117,099,153 | -11,844,149 | 7.57 |
| 2026-01-15 | 117,099,153 | 119,070,866 | -1,971,713 | 10.13 |
| 2025-12-31 | 119,070,866 | 120,342,810 | -1,271,944 | 8.86 |
| 2025-12-15 | 120,342,810 | 118,939,462 | +1,403,348 | 12.67 |
| 2025-11-28 | 118,939,462 | 115,733,068 | +3,206,394 | 11.83 |
| 2025-11-14 | 115,733,068 | 95,415,882 | +20,317,186 | 4.04 |
| 2025-10-31 | 95,415,882 | 83,612,571 | +11,803,311 | 7.42 |
| 2025-10-15 | 83,612,571 | 72,971,971 | +10,640,600 | 7.39 |
| 2025-09-30 | 72,971,971 | 65,704,715 | +7,267,256 | 7.20 |
| 2025-09-15 | 65,704,715 | 71,319,978 | -5,615,263 | 7.06 |
| 2025-08-29 | 71,319,978 | 71,364,792 | -44,814 | 5.71 |
| 2025-08-15 | 71,364,792 | 67,706,980 | +3,657,812 | 4.20 |
| 2025-07-31 | 67,706,980 | 98,633,209 | -30,926,229 | 2.12 |
| 2025-07-15 | 98,633,209 | 96,777,448 | +1,855,761 | 7.21 |
Showing 1–24 of 24 settlements
Key facts
CIK
1425205
CUSIP
462260100
13F (30d)
11 filings
10 filers
Visit website
Investor relations